Cell inspired delivery system equipped with natural membrane structures in applications for rescuing ischemic stroke

被引:0
作者
Zhu, Anran [1 ,2 ]
Jiang, Yingyu [1 ,2 ]
Pan, Longxiang [1 ,2 ]
Li, Jiale [1 ,2 ]
Huang, Yao [1 ,2 ]
Shi, Minghui [1 ,2 ]
Di, Liuqing [1 ,2 ]
Wang, Lei [3 ,4 ,5 ]
Wang, Ruoning [1 ,2 ]
机构
[1] Nanjing Univ Chinese Med, Jiangsu Prov TCM Engn Technol Res Ctr High Efficie, Sch Pharm, Nanjing 210023, Peoples R China
[2] Nanjing Univ Chinese Med, State Key Lab Technol Chinese Med Pharmaceut Proc, Nanjing 210023, Peoples R China
[3] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Peoples R China
[4] China Pharmaceut Univ, Jiangsu Key Lab Drug Design & Optimizat, Nanjing 210009, Peoples R China
[5] China Pharmaceut Univ, Sch Pharm, Dept Med Chem, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
Natural membrane; Brain targeting; Drug delivery; Nanotechnology; Ischemic stroke; BLOOD-BRAIN-BARRIER; ASTROCYTE-DERIVED EXOSOMES; MESENCHYMAL STEM-CELLS; TARGETED DRUG-DELIVERY; EXTRACELLULAR VESICLES; CEREBRAL-ISCHEMIA; GLYCOPROTEIN-IB; NITRIC-OXIDE; COATED NANOPARTICLES; SUPEROXIDE-DISMUTASE;
D O I
10.1016/j.jconrel.2024.11.013
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Ischemic stroke (IS), accounting for 87 % of stroke incidences, constitutes a paramount health challenge owing to neurological impairments and irreversible tissue damage arising from cerebral ischemia. Chief among therapeutic obstacles are the restrictive penetration of the blood-brain barrier (BBB) and insufficient targeting precision, hindering the accumulation of drugs in ischemic brain areas. Motivated by the remarkable capabilities of natural membrane-based delivery vehicles in achieving targeted delivery and traversing the BBB, thanks to their biocompatible architecture and bioactive components, numerous membrane-engineered systems such as cells, cell membranes and extracellular vesicles have emerged as promising platforms to augment IS treatment efficacy with the help of nanotechnology. This review consolidates the primary pathological manifestations following IS, elucidates the unique functionalities of natural membrane drug delivery systems (DDSs) with nanotechnology, as well as delineates the structural characteristics of various natural membranes alongside rational design strategies employed. The review illuminates both the potential and challenges encountered when employing natural membrane DDSs in IS drug therapy, offering fresh perspectives and insights for devising efficacious and practical delivery systems tailored to IS intervention.
引用
收藏
页码:54 / 80
页数:27
相关论文
共 299 条
  • [41] The platelet glycoprotein Ib-von Willebrand factor interaction activates the collagen receptor α2β1 to bind collagen:: activation-dependent conformational change of the α2-I domain
    Cruz, MA
    Chen, JM
    Whitelock, JL
    Morales, LD
    López, JA
    [J]. BLOOD, 2005, 105 (05) : 1986 - 1991
  • [42] Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke
    Cui, Xu
    Chen, Jieli
    Zacharek, Alex
    Li, Yi
    Roberts, Cynthia
    Kapke, Alissa
    Savant-Bhonsale, Smita
    Chopp, Michael
    [J]. STEM CELLS, 2007, 25 (11) : 2777 - 2785
  • [43] Targeting the blood-brain barrier for the delivery of stroke therapies
    D'Souza, Anisha
    Dave, Kandarp M.
    Stetler, R. Anne
    Manickam, Devika S.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2021, 171 : 332 - 351
  • [44] Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms
    Dad, Haseeb Anwar
    Gu, Ting-Wei
    Zhu, Ao-Qing
    Huang, Lu-Qi
    Peng, Li-Hua
    [J]. MOLECULAR THERAPY, 2021, 29 (01) : 13 - 31
  • [45] SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells
    De Falco, E
    Porcelli, D
    Torella, AR
    Straino, S
    Iachininoto, MG
    Orlandi, A
    Truffa, S
    Biglioli, P
    Napolitano, M
    Capogrossi, MC
    Pesce, M
    [J]. BLOOD, 2004, 104 (12) : 3472 - 3482
  • [46] Neural Stem Cell Transplantation for Neurodegenerative Diseases
    De Gioia, Roberta
    Biella, Fabio
    Citterio, Gaia
    Rizzo, Federica
    Abati, Elena
    Nizzardo, Monica
    Bresolin, Nereo
    Comi, Giacomo Pietro
    Corti, Stefania
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (09)
  • [47] Roles and therapeutic potential of different extracellular vesicle subtypes on traumatic brain injury
    Dong, Xinlong
    Dong, Jing-fei
    Zhang, Jianning
    [J]. CELL COMMUNICATION AND SIGNALING, 2023, 21 (01)
  • [48] Neutrophil Membrane-Derived Nanovesicles Alleviate Inflammation To Protect Mouse Brain Injury from Ischemic Stroke
    Dong, Xinyue
    Gao, Jin
    Zhang, Can Yang
    Hayworth, Christopher
    Frank, Marcos
    Wang, Zhenjia
    [J]. ACS NANO, 2019, 13 (02) : 1272 - 1283
  • [49] A Homing Peptide Modified Neutrophil Membrane Biomimetic Nanoparticles in Response to ROS/inflammatory Microenvironment for Precise Targeting Treatment of Ischemic Stroke
    Dong, Zhufeng
    Tang, Lin
    Zhang, Yu
    Ma, Xiaoyue
    Yin, Ying
    Kuang, Lei
    Fan, Qin
    Wang, Bingyi
    Hu, Xiaoye
    Yin, Tieying
    Wang, Yazhou
    [J]. ADVANCED FUNCTIONAL MATERIALS, 2024, 34 (04)
  • [50] Astrocyte-derived exosomes carry microRNA-17-5p to protect neonatal rats from hypoxic-ischemic brain damage via inhibiting BNIP-2 expression
    Du, Lin
    Jiang, Yuying
    Sun, Ying
    [J]. NEUROTOXICOLOGY, 2021, 83 : 28 - 39